INIS
carcinomas
100%
patients
68%
surgery
35%
photodynamic therapy
32%
tomography
31%
risks
18%
diseases
15%
uracils
15%
tumors
14%
biopsy
13%
guidelines
12%
mutations
11%
failures
10%
bcc lattices
9%
aminolevulinic acid
8%
assessments
8%
clinical trials
8%
images
8%
netherlands
7%
therapy
7%
detection
7%
comparative evaluations
7%
data
6%
genes
6%
genetics
6%
reviews
5%
accuracy
5%
applications
5%
skin
5%
evaluation
5%
Keyphrases
Basal Cell Carcinoma
46%
Superficial Basal Cell Carcinoma
29%
Photodynamic Therapy
28%
Optical Coherence Tomography
24%
Confidence Interval
19%
Basal Cell Nevus Syndrome
18%
Surgical Excision
18%
Actinic Keratosis
16%
Imiquimod
14%
Methyl Aminolevulinate
13%
Bowen's Disease
13%
5-fluorouracil (5-FU)
13%
Randomized Controlled Trial
12%
Non-invasive Treatment
10%
Treatment Failure
10%
Punch Biopsy
9%
Nodular Basal Cell Carcinoma
9%
Tumor
8%
Netherlands
8%
Randomized Clinical Trial
7%
Non-inferiority Randomized Controlled Trial
7%
Multiple Basal Cell Carcinomas
6%
Histological Subtypes
6%
5-aminolevulinic Acid Photodynamic Therapy
6%
Discrete Choice Experiment
6%
Cutaneous Squamous Cell Carcinoma (cSCC)
6%
5-fluorouracil Cream
6%
Methyl Aminolaevulinate
6%
PTCH1
5%
Imiquimod Cream
5%
Medicine and Dentistry
Basal-Cell Carcinoma
54%
Photochemotherapy
31%
Optical Coherence Tomography
30%
Randomized Controlled Trial
23%
Superficial Basal Cell Carcinoma
22%
Fluorouracil
21%
Aminolevulinic Acid Methyl Ester
18%
Imiquimod
15%
Neoplasm
13%
Gorlin Syndrome
11%
Actinic Keratosis
11%
Bowen's Disease
11%
Punch Biopsy
9%
Nodular Basal Cell Carcinoma
9%
Aminolevulinic Acid
8%
Recurrent Disease
8%
Non Invasive Procedure
8%
Hedgehog Signaling
7%
Skin Carcinoma
6%
Randomized Clinical Trial
5%
Biopsy Technique
5%
Vismodegib
5%
Cosmetics
5%
